<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38841730</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2162-3279</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Brain and behavior</Title><ISOAbbreviation>Brain Behav</ISOAbbreviation></Journal><ArticleTitle>Olfactory dysfunction as an early predictor for post-COVID condition at 1-year follow-up.</ArticleTitle><Pagination><StartPage>e3574</StartPage><MedlinePgn>e3574</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e3574</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/brb3.3574</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Olfactory dysfunction together with neurological and cognitive symptoms are common after COVID-19. We aimed to study whether performance on olfactory and neuropsychological tests following infection predict post-COVID condition (PCC), persisting symptoms, and reduced health-related quality of life.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Both hospitalized (N&#xa0;=&#xa0;10) and non-hospitalized individuals (N&#xa0;=&#xa0;56) were enrolled in this prospective cohort study. Participants were evaluated 1-3 months after infection with an olfactory threshold test and neuropsychological tests, which was used as predictors of PCC. A questionnaire outlining persisting symptoms and the validated instrument EuroQol five-dimension five-level for health-related quality of life assessment were used as outcome data 1 year after infection (N&#xa0;=&#xa0;59). Principal component analysis was used to identify relevant predictors for PCC at 1 year.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Objectively assessed olfactory dysfunction at 1-3 months post infection, but not subjective olfactory symptoms, predicted post-COVID condition with reduced health-related quality of life (PCC+) at 1 year. The PCC+ group scored more often below the cut off for mild cognitive impairment on the Montreal Cognitive Assessment (61.5%&#xa0;vs. 21.7%) and higher on the Multidimensional Fatigue Inventory-20, compared to the group without PCC+.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results indicate that objectively assessed, olfactory dysfunction is a predictor for PCC+. These findings underscore the importance of objective olfactory testing. We propose that olfactory screening in the early post-acute phase of COVID-19 infection might identify individuals that are at higher risk of developing long-term health sequalae.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Brain and Behavior published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Granvik</LastName><ForeName>Christoffer</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersson</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Integrative Medical Biology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersson</LastName><ForeName>Linus</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Psychology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brorsson</LastName><ForeName>Camilla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Diagnostics and Intervention, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forsell</LastName><ForeName>Mattias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahlm</LastName><ForeName>Clas</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Normark</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edin</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0309-1852</Identifier><AffiliationInfo><Affiliation>Department of Diagnostics and Intervention, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2020-06235</GrantID><Agency>Swedish Research Council</Agency><Country/></Grant><Grant><GrantID>2016-06514</GrantID><Agency>Swedish Research Council</Agency><Country/></Grant><Grant><GrantID>20200325</GrantID><Agency>Hj&#xe4;rt-Lungfonden</Agency><Country/></Grant><Grant><GrantID>20210078</GrantID><Agency>Hj&#xe4;rt-Lungfonden</Agency><Country/></Grant><Grant><GrantID>VC-2020-0015</GrantID><Agency>Knut och Alice Wallenbergs Stiftelse</Agency><Country/></Grant><Grant><GrantID>VLL 1925-2017</GrantID><Agency>Knut och Alice Wallenbergs Stiftelse</Agency><Country/></Grant><Grant><GrantID>FS 2.1.6-849-20</GrantID><Agency>Knut och Alice Wallenbergs Stiftelse</Agency><Country/></Grant><Grant><GrantID>RV-938855</GrantID><Agency>County Council of V&#xe4;sterbotten</Agency><Country/></Grant><Grant><GrantID>RV-939393</GrantID><Agency>County Council of V&#xe4;sterbotten</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Behav</MedlineTA><NlmUniqueID>101570837</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="Y">Olfaction Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="Y">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">health&#x2010;related quality of life</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">olfactory dysfunction</Keyword><Keyword MajorTopicYN="N">post&#x2010;COVID condition (PCC)</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>6</Day><Hour>4</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38841730</ArticleId><ArticleId IdType="pmc">PMC11154814</ArticleId><ArticleId IdType="doi">10.1002/brb3.3574</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmad, I. , Edin, A. , Granvik, C. , Kumm Persson, L. , Tevell, S. , M&#xe5;nsson, E. , Magnuson, A. , Marklund, I. , Persson, I.&#x2010;L. , Kauppi, A. , Ahlm, C. , Forsell, M. N. E. , Sundh, J. , Lange, A. , Cajander, S. , &amp; Normark, J. (2023). High prevalence of persistent symptoms and reduced health&#x2010;related quality of life 6 months after COVID&#x2010;19. Frontiers in Public Health, 11, 1104267. 10.3389/fpubh.2023.1104267</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1104267</ArticleId><ArticleId IdType="pmc">PMC9932930</ArticleId><ArticleId IdType="pubmed">36817925</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson, L. , Sandberg, P. , &#xc5;str&#xf6;m, E. , Lillqvist, M. , &amp; Claeson, A.&#x2010;S. (2020). Chemical intolerance is associated with altered response bias, not greater sensory sensitivity. i&#x2010;Perception, 11, 204166952097842. 10.1177/2041669520978424</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2041669520978424</ArticleId><ArticleId IdType="pmc">PMC7754803</ArticleId><ArticleId IdType="pubmed">33425314</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker, J. H. , Lin, J. J. , Doernberg, M. , Stone, K. , Navis, A. , Festa, J. R. , &amp; Wisnivesky, J. P. (2021). Assessment of cognitive function in patients after COVID&#x2010;19 infection. JAMA Network Open, 4(10), e2130645. 10.1001/jamanetworkopen.2021.30645</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.30645</ArticleId><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Borg, E. , &amp; Borg, G. (2002). A comparison of AME and CR100 for scaling perceived exertion. Acta Psychologica, 109, 157&#x2013;175. 10.1016/S0001-6918(01)00055-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0001-6918(01)00055-5</ArticleId><ArticleId IdType="pubmed">11820425</ArticleId></ArticleIdList></Reference><Reference><Citation>Cain, W. S. , Goodspeed, R. B. , Gent, J. F. , &amp; Leonard, G. (1988). Evaluation of olfactory dysfunction in the connecticut chemosensory clinical research center. The Laryngoscope, 98(1), 83&#x2013;88. 10.1288/00005537-198801000-00017</Citation><ArticleIdList><ArticleId IdType="doi">10.1288/00005537-198801000-00017</ArticleId><ArticleId IdType="pubmed">3336267</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavazzana, A. , R&#xf6;hrborn, A. , Garthus&#x2010;Niegel, S. , Larsson, M. , Hummel, T. , &amp; Croy, I. (2018). Sensory&#x2010;specific impairment among older people. An investigation using both sensory thresholds and subjective measures across the five senses. PLoS ONE, 13(8), e0202969. 10.1371/journal.pone.0202969</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0202969</ArticleId><ArticleId IdType="pmc">PMC6110574</ArticleId><ArticleId IdType="pubmed">30148857</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban, F. , Ling, S. , Lui, L. M. W. , Lee, Y. , Gill, H. , Teopiz, K. M. , Rodrigues, N. B. , Subramaniapillai, M. , Di Vincenzo, J. D. , Cao, B. , Lin, K. , Mansur, R. B. , Ho, R. C. , Rosenblat, J. D. , Miskowiak, K. W. , Vinberg, M. , Maletic, V. , &amp; Mcintyre, R. S. (2022). Fatigue and cognitive impairment in post&#x2010;COVID&#x2010;19 syndrome: A systematic review and meta&#x2010;analysis. Brain, Behavior, and Immunity, 101, 93&#x2013;135. 10.1016/j.bbi.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Collaborators GBoDLC . (2022). Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID&#x2010;19 in 2020 and 2021. JAMA, 328(16), 1604&#x2013;1615. 10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristillo, V. , Pilotto, A. , Cotti Piccinelli, S. , Zoppi, N. , Bonzi, G. , Gipponi, S. , Sattin, D. , Schiavolin, S. , Raggi, A. , Bezzi, M. , Leonardi, M. , &amp; Padovani, A. (2021). Age and subtle cognitive impairment are associated with long&#x2010;term olfactory dysfunction after COVID&#x2010;19 infection. Journal of the American Geriatrics Society, 69(10), 2778&#x2013;2780. 10.1111/jgs.17296</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17296</ArticleId><ArticleId IdType="pmc">PMC8242714</ArticleId><ArticleId IdType="pubmed">34019707</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto, O. H. , Rumbea, D. A. , Recalde, B. Y. , &amp; Mera, R. M. (2022). Cognitive sequelae of long COVID may not be permanent: A prospective study. European Journal of Neurology, 29(4), 1218&#x2013;1221. 10.1111/ene.15215</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15215</ArticleId><ArticleId IdType="pubmed">34918425</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stadio, A. , Brenner, M. J. , De Luca, P. , Albanese, M. , D'ascanio, L. , Ralli, M. , Roccamatisi, D. , Cingolani, C. , Vitelli, F. , Camaioni, A. , Di Girolamo, S. , &amp; Bernitsas, E. (2022). Olfactory dysfunction, headache, and mental clouding in adults with long&#x2010;COVID&#x2010;19: What is the link between cognition and olfaction? A cross&#x2010;sectional study. Brain Science, 12(2), 154. 10.3390/brainsci12020154</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12020154</ArticleId><ArticleId IdType="pmc">PMC8870047</ArticleId><ArticleId IdType="pubmed">35203918</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty, R. L. (2022). Olfactory dysfunction in COVID&#x2010;19: Pathology and long&#x2010;term implications for brain health. Trends in Molecular Medicine, 28(9), 781&#x2013;794. 10.1016/j.molmed.2022.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2022.06.005</ArticleId><ArticleId IdType="pmc">PMC9212891</ArticleId><ArticleId IdType="pubmed">35810128</ArticleId></ArticleIdList></Reference><Reference><Citation>ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals) . (2003). n&#x2010;Butanol (CAS No.71&#x2010;36&#x2010;3). JACC No. 41.</Citation></Reference><Reference><Citation>Evans, R. A. , Mcauley, H. , Harrison, E. M. , Shikotra, A. , Singapuri, A. , Sereno, M. , Elneima, O. , Docherty, A. B. , Lone, N. I. , Leavy, O. C. , Daines, L. , Baillie, J. K. , Brown, J. S. , Chalder, T. , De Soyza, A. , Diar Bakerly, N. , Easom, N. , Geddes, J. R. , Greening, N. J. , &#x2026; Zongo, O. (2021). Physical, cognitive, and mental health impacts of COVID&#x2010;19 after hospitalisation (PHOSP&#x2010;COVID): A UK multicentre, prospective cohort study. The Lancet Respiratory Medicine, 9, 1275&#x2013;1287. 10.1016/S2213-2600(21)00383-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke, C. , Boesl, F. , Goereci, Y. , Gerhard, A. , Schweitzer, F. , Schroeder, M. , Foverskov&#x2010;Rasmussen, H. , Heine, J. , Quitschau, A. , Kandil, F. I. , Schild, A.&#x2010;K. , Finke, C. , Audebert, H. J. , Endres, M. , Warnke, C. , &amp; Pr&#xfc;ss, H. (2023). Association of cerebrospinal fluid brain&#x2010;binding autoantibodies with cognitive impairment in post&#x2010;COVID&#x2010;19 syndrome. Brain, Behavior, and Immunity, 109, 139&#x2013;143. 10.1016/j.bbi.2023.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.01.006</ArticleId><ArticleId IdType="pmc">PMC9841734</ArticleId><ArticleId IdType="pubmed">36657623</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris, P. A. , Taylor, R. , Thielke, R. , Payne, J. , Gonzalez, N. , &amp; Conde, J. G. (2009). Research electronic data capture (REDCap)&#x2014;A metadata&#x2010;driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377&#x2013;381. 10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel, T. , Whitcroft, K. L. , Andrews, P. , Altundag, A. , Cinghi, C. , Costanzo, R. M. , Damm, M. , Frasnelli, J. , Gudziol, H. , Gupta, N. , Haehne, A. , Holbrook, E. , Hong, S. C. , Hornung, D. , Huttenbrink, K. B. , Kamel, R. , Kobayashi, M. , Konstantinidis, I. , Landis, B. N. , &#x2026; Welge&#x2010;Luessen, A. (2017). Position paper on olfactory dysfunction. Rhinology Supplement, 54(26), 1&#x2013;30. 10.4193/Rhino16.248</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhino16.248</ArticleId><ArticleId IdType="pubmed">29528615</ArticleId></ArticleIdList></Reference><Reference><Citation>Josse, J. , &amp; Husson, F. (2016). missMDA: A package for handling missing values in multivariate data analysis. Journal of Statistical Software, 70(1), 1&#x2013;31. 10.18637/jss.v070.i01</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v070.i01</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien, J. R. , Vaira, L. A. , &amp; Saussez, S. (2023). Prevalence and 24&#x2010;month recovery of olfactory dysfunction in COVID&#x2010;19 patients: A multicentre prospective study&#x2014;Lechien&#x2013;2023. Journal of Internal Medicine, 293(1), 82&#x2013;90. 10.1111/joim.13564</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13564</ArticleId><ArticleId IdType="pmc">PMC9538281</ArticleId><ArticleId IdType="pubmed">36000469</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke, J. , L&#xfc;tgehetmann, M. , Hagel, C. , Sperhake, J. P. , Schr&#xf6;der, A. S. , Edler, C. , Mushumba, H. , Fitzek, A. , Allweiss, L. , Dandri, M. , Dottermusch, M. , Heinemann, A. , Pfefferle, S. , Schwabenland, M. , Sumner Magruder, D. , Bonn, S. , Prinz, M. , Gerloff, C. , P&#xfc;schel, K. , &#x2026; Glatzel, M. (2020). Neuropathology of patients with COVID&#x2010;19 in Germany: A post&#x2010;mortem case series. The Lancet Neurology, 19(11), 919&#x2013;929. 10.1016/S1474-4422(20)30308-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattioli, F. , Piva, S. , Stampatori, C. , Righetti, F. , Mega, I. , Peli, E. , Sala, E. , Tomasi, C. , Indelicato, A. M. , Latronico, N. , &amp; De Palma, G. (2022). Neurologic and cognitive sequelae after SARS&#x2010;CoV2 infection: Different impairment for ICU patients. Journal of the Neurological Sciences, 432, 120061. 10.1016/j.jns.2021.120061</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.120061</ArticleId><ArticleId IdType="pmc">PMC8620095</ArticleId><ArticleId IdType="pubmed">34894422</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza, M. G. , Palladini, M. , De Lorenzo, R. , Magnaghi, C. , Poletti, S. , Furlan, R. , Ciceri, F. , Rovere&#x2010;Querini, P. , &amp; Benedetti, F. (2021). Persistent psychopathology and neurocognitive impairment in COVID&#x2010;19 survivors: Effect of inflammatory biomarkers at three&#x2010;month follow&#x2010;up. Brain, Behavior, and Immunity, 94, 138&#x2013;147. 10.1016/j.bbi.2021.02.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru, S. , &amp; Merad, M. (2022). Pathological sequelae of long&#x2010;haul COVID. Nature Immunology, 23(2), 194&#x2013;202. 10.1038/s41590-021-01104-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Moein, S. , Hashemian, S. , Tabarsi, P. , &amp; Doty, R. (2020). Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID&#x2010;19 patients. International Forum of Allergy &amp; Rhinology, 10(10), 1127&#x2013;1135. 10.1002/alr.22680</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22680</ArticleId><ArticleId IdType="pmc">PMC7436559</ArticleId><ArticleId IdType="pubmed">32761796</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine, Z. S. , Phillips, N. A. , B&#xe9;dirian, V. , Charbonneau, S. , Whitehead, V. , Collin, I. , Cummings, J. L. , &amp; Chertkow, H. (2005). The Montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695&#x2013;699. 10.1111/j.1532-5415.2005.53221.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama, O. , Taniguchi, H. , Kondoh, Y. , Kimura, T. , Kato, K. , Kataoka, K. , Ogawa, T. , Watanabe, F. , &amp; Arizono, S. (2010). A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. European Respiratory Journal, 36, 1067&#x2013;1072. 10.1183/09031936.00152609</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00152609</ArticleId><ArticleId IdType="pubmed">20413545</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordin, M. , &#xc5;kerstedt, T. , &amp; Nordin, S. (2013). Psychometric evaluation and normative data for the Karolinska Sleep Questionnaire. Sleep and Biological Rhythms, 11(4), 216&#x2013;226. 10.1111/sbr.12024</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sbr.12024</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh, C. , Darley, D. R. , Wilson, D. B. , Howe, A. , Munier, C. M. L , Patel, S. K. , Juno, J. A. , Burrell, L. M. , Kent, S. J. , Dore, G. J. , Kelleher, A. D. , &amp; Matthews, G V. (2022). Immunological dysfunction persists for 8 months following initial mild&#x2010;to&#x2010;moderate SARS&#x2010;CoV&#x2010;2 infection. Nature Immunology, 23(2), 210&#x2013;216. 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Pihlaja, R. , Kauhanen, L. , Ollila, H. , Tuulio&#x2010;Henriksson, A. S. , Koskinen, S. K. , Tiainen, M. , Salmela, V. R. , H&#xe4;stbacka, J. , &amp; Hokkanen, L. S. (2023). Associations of subjective and objective cognitive functioning after COVID&#x2010;19: A six&#x2010;month follow&#x2010;up of ICU, ward, and home&#x2010;isolated patients. Brain, Behavior, &amp; Immunity&#x2014;Health, 27, 100587. 10.1016/j.bbih.2023.100587</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2023.100587</ArticleId><ArticleId IdType="pmc">PMC9812472</ArticleId><ArticleId IdType="pubmed">36624888</ArticleId></ArticleIdList></Reference><Reference><Citation>Randolph, C. (2013). Repeatable battery for the assessment of neuropsychological status (RBANS) (Swedish ed.). Stockholm: Pearson Assessment.</Citation></Reference><Reference><Citation>Randolph, C. , Tierney, M. C. , Mohr, E. , &amp; Chase, T N. (1998). The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary clinical validity. Journal of Clinical and Experimental Neuropsychology, 20(3), 310&#x2013;319. 10.1076/jcen.20.3.310.823</Citation><ArticleIdList><ArticleId IdType="doi">10.1076/jcen.20.3.310.823</ArticleId><ArticleId IdType="pubmed">9845158</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass, V. , Beer, R. , Schiefecker, A. J. , Lindner, A. , Kofler, M. , Ianosi, B. A. , Mahlknecht, P. , Heim, B. , Peball, M. , Carbone, F. , Limmert, V. , Kindl, P. , Putnina, L. , Fava, E. , Sahanic, S. , Sonnweber, T. , L&#xf6;scher, W. N. , Wanschitz, J. V. , Zamarian, L. , &#x2026; Helbok, R. (2022). Neurological outcomes 1 year after COVID&#x2010;19 diagnosis: A prospective longitudinal cohort study. European Journal of Neurology, 29, 1685&#x2013;1696. 10.1111/ene.15307</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15307</ArticleId><ArticleId IdType="pmc">PMC9111823</ArticleId><ArticleId IdType="pubmed">35239247</ArticleId></ArticleIdList></Reference><Reference><Citation>Roffman, C. E. , Buchanan, J. , &amp; Allison, G. T. (2016). Charlson comorbidities index. Journal of Physiotherapy, 62(3), 171. 10.1016/j.jphys.2016.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphys.2016.05.008</ArticleId><ArticleId IdType="pubmed">27298055</ArticleId></ArticleIdList></Reference><Reference><Citation>Smets, E. M. A. , Garssen, B. , Bonke, B. , &amp; De Haes, J. C. J. M. (1995). The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. Journal of Psychosomatic Research, 39(3), 315&#x2013;325. 10.1016/0022-3999(94)00125-O</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(94)00125-O</ArticleId><ArticleId IdType="pubmed">7636775</ArticleId></ArticleIdList></Reference><Reference><Citation>Talavera, B. , Garc&#xed;a&#x2010;Azor&#xed;n, D. , Mart&#xed;nez&#x2010;P&#xed;as, E. , Trigo, J. , Hern&#xe1;ndez&#x2010;P&#xe9;rez, I. , Valle&#x2010;Pe&#xf1;acoba, G. , Sim&#xf3;n&#x2010;Campo, P. , De Lera, M. , Chavarr&#xed;a&#x2010;Miranda, A. , L&#xf3;pez&#x2010;Sanz, C. , Guti&#xe9;rrez&#x2010;S&#xe1;nchez, M. , Mart&#xed;nez&#x2010;Velasco, E. , Pedraza, M. , Sierra, &#xc1;. , G&#xf3;mez&#x2010;Vicente, B. , Guerrero, &#xc1;. , &amp; Arenillas, J. F. (2020). Anosmia is associated with lower in&#x2010;hospital mortality in COVID&#x2010;19. Journal of the Neurological Sciences, 419, 117163. 10.1016/j.jns.2020.117163</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117163</ArticleId><ArticleId IdType="pmc">PMC7527278</ArticleId><ArticleId IdType="pubmed">33035870</ArticleId></ArticleIdList></Reference><Reference><Citation>Thronicke, A. , Hinse, M. , Weinert, S. , Jakubowski, A. , Grieb, G. , &amp; Matthes, H. (2022). Factors associated with self&#x2010;reported post/long&#x2010;COVID&#x2014;A real&#x2010;world data study. International Journal of Environmental Research and Public Health, 19(23), 16124. 10.3390/ijerph192316124</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316124</ArticleId><ArticleId IdType="pmc">PMC9738553</ArticleId><ArticleId IdType="pubmed">36498197</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Regemorter, V. , Hummel, T. , Rosenzweig, F. , Mouraux, A. , Rombaux, P. , &amp; Huart, C. (2020). Mechanisms linking olfactory impairment and risk of mortality. Frontiers in Neuroscience, 14, 140. 10.3389/fnins.2020.00140</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00140</ArticleId><ArticleId IdType="pmc">PMC7046549</ArticleId><ArticleId IdType="pubmed">32153360</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler, D. (2008). Wechsler Adult Intelligence Scale&#x2013;Fourth edition (WAIS&#x2010;IV). APA PsycTests. 10.1037/t15169-000</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/t15169-000</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler, D. (2010). Wechsler Adult Intelligence Scale&#x2014;Fourth edition (Swedish ed.). APA PsycTests.</Citation></Reference><Reference><Citation>
WHO
. (2021). A clinical case definition of post COVID&#x2010;19 condition by a Delphi consensus. https://www.who.int/publications/i/item/WHO&#x2010;2019&#x2010;nCoV&#x2010;Post_COVID&#x2010;19_condition&#x2010;Clinical_case_definition&#x2010;2021.1
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO
. (2024). WHO coronavirus (COVID&#x2010;19) dashboard. https://covid19.who.int
</Citation></Reference><Reference><Citation>Xydakis, M. S. , Albers, M. W. , Holbrook, E. H. , Lyon, D. M. , Shih, R. Y. , Frasnelli, J. A. , Pagenstecher, A. , Kupke, A. , Enquist, L. W. , &amp; Perlman, S. (2021). Post&#x2010;viral effects of COVID&#x2010;19 in the olfactory system and their implications. Lancet Neurology, 20(9), 753&#x2013;761. 10.1016/S1474-4422(21)00182-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00182-4</ArticleId><ArticleId IdType="pmc">PMC8324113</ArticleId><ArticleId IdType="pubmed">34339626</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng, N. , Zhao, Y.&#x2010;M. , Yan, W. , Li, C. , Lu, Q.&#x2010;D. , Liu, L. , Ni, S.&#x2010;Y. , Mei, H. , Yuan, K. , Shi, L. , Li, P. , Fan, T.&#x2010;T. , Yuan, J.&#x2010;L. , Vitiello, M. V. , Kosten, T. , Kondratiuk, A. L. , Sun, H.&#x2010;Q. , Tang, X.&#x2010;D. , Liu, M.&#x2010;Y. , &#x2026; Lu, L. (2022). A systematic review and meta&#x2010;analysis of long term physical and mental sequelae of COVID&#x2010;19 pandemic: Call for research priority and action. Molecular Psychiatry, 28(1), 423&#x2013;433. 10.1038/s41380-022-01614-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01614-7</ArticleId><ArticleId IdType="pmc">PMC9168643</ArticleId><ArticleId IdType="pubmed">35668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond, A. S. , &amp; Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361&#x2013;370. 10.1111/j.1600-0447.1983.tb09716.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>